Hledání článků
Filtry
Anderson CS, Huang Y, Lindley RI, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open label, blinded endpoint, phase 3 trial.
Lancet 2019 Feb 6. pii: S0140 6736(19)30038 8. doi: 10.1016/S0140 6736(19)30038 8. [Epub ahead of print]
Krediet RT. Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis.
Front Physiol 2018;9:1815.
Ohkuma T, Jun M, Rodgers A, et al.; ADVANCE Collaborative Group. Acute increases in serum creatinine after starting angiotensin converting enzyme inhibitor based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus.
Hypertension 2019;73:84–91.
Fernandez‑Juarez G, Perez JV, Caravaca‑Fontán F, et al.; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis.
Clin J Am Soc Nephrol 2018;13:1851–1858.
Jones RB, Hiemstra TF, Ballarin J, et al.; European Vasculitis Study Group (EUVAS). Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA‑associated vasculitis: a randomised, non‑inferiority trial.
Ann Rheum Dis 2019;78:399–405.
Madsen CV, Granqvist H, Petersen HJ, et al. Age‑related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study.
Nephrol Dial Transplant 2018;10:1–9.
Jaber S, Paugam C, Futier E, et al.; BICAR‑ICU Study Group. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR‑ICU): a multicentre, open‑label, randomised controlled, phase 3 trial.
Lancet 2018;392:31–40.
Zhang Z, Zhu C, Mo L, Hong Y. Effectiveness of sodium bicarbonate infusion on mortality in septic patients with metabolic acidosis.
Intensive Care Med 2018;44:1888–1895
Kraus D, von Jeinsen B, Tzikas S, et al. Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease.
J Am Heart Assoc 2018;7:e008032.
Calderon‑Margalit R, Golan E, Twig G, et al.
History of Childhood Kidney Disease and Risk of Adult End‑Stage Renal Disease. N Engl J Med 2018;378:428–438.
Gomez Mendez LM, Cascino MD, Garg J, et al.
Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis. Clin J Am Soc Nephrol 2018;13:1502–1509
Nataatmadja MS, Johnson DW, Pascoe EM, et al.;
balANZ Trial Investigators. Associations between peritoneal glucose exposure, glucose degradation product exposure, and peritoneal membrane transport characteristics in peritoneal dialysis patients: secondary analysis of the balANZ trial.Perit Dial Int 2018;38:349–355.
Schaefer F, Ardissino G, Ariceta G, et al.;
Kidney Int 2018;94:408–418.